Skip to main content
NCBI home page
Biophysical Journal logoLink to Biophysical Journal
. 1990 Aug;58(2):471–481. doi: 10.1016/S0006-3495(90)82392-4

Direct binding of verapamil to the ryanodine receptor channel of sarcoplasmic reticulum.

H H Valdivia 1, C Valdivia 1, J Ma 1, R Coronado 1
PMCID: PMC1280987  PMID: 2169916

Abstract

Radioligand binding experiments and single channel recordings demonstrate that verapamil interacts with the ryanodine receptor Ca2+ release channel of the sarcoplasmic reticulum of rabbit skeletal muscle. In isolated triads, verapamil decreased binding of [3H]Ryanodine with an IC50 of approximately 8 microM at an optimal pH 8.5 and pCa 4.3. Nitrendipine and d-cis-diltiazem did not interfere with binding of [3H]Ryanodine to triads, suggesting that the action of verapamil does not involve the dihydropyridine receptor. Single channel recordings showed that verapamil blocked Ca2+ release channels by decreasing open probability, duration of open events, and number of events per unit time. A direct interaction of verapamil with the ryanodine receptor peptide was demonstrated after purification of the approximately 400 kDa receptor protein from Chaps-solubilized triads. The purified receptor displayed high affinity for [3H]Ryanodine with a Kd of approximately 5 nM and a Bmax of approximately 400 pmol/mg. Verapamil and D600 decreased [3H]Ryanodine binding noncompetitively by reducing the Bmax. Thus the presence of binding sites for phenylalkylamines in the Ca2+ release channel was confirmed. Verapamil blockade of Ca2+ release channels may explain some of the paralyzing effects of phenylalkylamines observed during excitation-contraction coupling of skeletal muscle.

Full text

PDF
471

Images in this article

477FIGURE 5
on p.477

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong C. M., Bezanilla F. M., Horowicz P. Twitches in the presence of ethylene glycol bis( -aminoethyl ether)-N,N'-tetracetic acid. Biochim Biophys Acta. 1972 Jun 23;267(3):605–608. doi: 10.1016/0005-2728(72)90194-6. [DOI] [PubMed] [Google Scholar]
  2. Balzer H. The effect of quinidine and drugs with quinidine-like action (propranolol, verapamil and tetracaine) on the calcium transport system in isolated sarcoplasmic reticulum vesicles of rabbit skeletal muscle. Naunyn Schmiedebergs Arch Pharmacol. 1972;274(3):256–272. doi: 10.1007/BF00501935. [DOI] [PubMed] [Google Scholar]
  3. Bean B. P. Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state. Proc Natl Acad Sci U S A. 1984 Oct;81(20):6388–6392. doi: 10.1073/pnas.81.20.6388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berwe D., Gottschalk G., Lüttgau H. C. Effects of the calcium antagonist gallopamil (D600) upon excitation-contraction coupling in toe muscle fibres of the frog. J Physiol. 1987 Apr;385:693–707. doi: 10.1113/jphysiol.1987.sp016515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Block B. A., Imagawa T., Campbell K. P., Franzini-Armstrong C. Structural evidence for direct interaction between the molecular components of the transverse tubule/sarcoplasmic reticulum junction in skeletal muscle. J Cell Biol. 1988 Dec;107(6 Pt 2):2587–2600. doi: 10.1083/jcb.107.6.2587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Caputo C., Bolaños P. Contractile inactivation in frog skeletal muscle fibers. The effects of low calcium, tetracaine, dantrolene, D-600, and nifedipine. J Gen Physiol. 1987 Mar;89(3):421–442. doi: 10.1085/jgp.89.3.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Catterall W. A., Seagar M. J., Takahashi M. Molecular properties of dihydropyridine-sensitive calcium channels in skeletal muscle. J Biol Chem. 1988 Mar 15;263(8):3535–3538. [PubMed] [Google Scholar]
  8. Cheng Y., Prusoff W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
  9. Eisenberg R. S., McCarthy R. T., Milton R. L. Paralysis of frog skeletal muscle fibres by the calcium antagonist D-600. J Physiol. 1983 Aug;341:495–505. doi: 10.1113/jphysiol.1983.sp014819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ellis S. B., Williams M. E., Ways N. R., Brenner R., Sharp A. H., Leung A. T., Campbell K. P., McKenna E., Koch W. J., Hui A. Sequence and expression of mRNAs encoding the alpha 1 and alpha 2 subunits of a DHP-sensitive calcium channel. Science. 1988 Sep 23;241(4873):1661–1664. doi: 10.1126/science.2458626. [DOI] [PubMed] [Google Scholar]
  11. Entman M. L., Allen J. C., Bornet E. P., Gillette P. C., Wallick E. T., Schwart A. Mechanisms of calcium accumulation and transport in cardiac relaxing system (sarcoplasmic reticulum membranes): effects of Verapamil, D-600, X537A and A23187. J Mol Cell Cardiol. 1972 Dec;4(6):681–687. doi: 10.1016/0022-2828(72)90121-6. [DOI] [PubMed] [Google Scholar]
  12. Erdmann R., Lüttgau H. C. The effect of the phenylalkylamine D888 (devapamil) on force and Ca2+ current in isolated frog skeletal muscle fibres. J Physiol. 1989 Jun;413:521–541. doi: 10.1113/jphysiol.1989.sp017667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fairhurst A. S., Thayer S. A., Colker J. E., Beatty D. A. A calcium antagonist drug binding site in skeletal muscle sarcoplasmic reticulum: evidence for a calcium channel. Life Sci. 1983 Mar 21;32(12):1331–1339. doi: 10.1016/0024-3205(83)90807-x. [DOI] [PubMed] [Google Scholar]
  14. Fill M. D., Best P. M. Block of contracture in skinned frog skeletal muscle fibers by calcium antagonists. J Gen Physiol. 1989 Mar;93(3):429–449. doi: 10.1085/jgp.93.3.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fosset M., Jaimovich E., Delpont E., Lazdunski M. [3H]nitrendipine receptors in skeletal muscle. J Biol Chem. 1983 May 25;258(10):6086–6092. [PubMed] [Google Scholar]
  16. Frelin C., Vigne P., Lazdunski M. Biochemical evidence for pharmacological similarities between alpha-adrenoreceptors and voltage-dependent Na+ and Ca++ channels. Biochem Biophys Res Commun. 1982 Jun 15;106(3):967–973. doi: 10.1016/0006-291x(82)91805-8. [DOI] [PubMed] [Google Scholar]
  17. Galizzi J. P., Borsotto M., Barhanin J., Fosset M., Lazdunski M. Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes. J Biol Chem. 1986 Jan 25;261(3):1393–1397. [PubMed] [Google Scholar]
  18. Galizzi J. P., Fosset M., Lazdunski M. Properties of receptors for the Ca2+-channel blocker verapamil in transverse-tubule membranes of skeletal muscle. Stereospecificity, effect of Ca2+ and other inorganic cations, evidence for two categories of sites and effect of nucleoside triphosphates. Eur J Biochem. 1984 Oct 15;144(2):211–215. doi: 10.1111/j.1432-1033.1984.tb08451.x. [DOI] [PubMed] [Google Scholar]
  19. Garcia M. L., Trumble M. J., Reuben J. P., Kaczorowski G. J. Characterization of verapamil binding sites in cardiac membrane vesicles. J Biol Chem. 1984 Dec 25;259(24):15013–15016. [PubMed] [Google Scholar]
  20. Gonzalez-Serratos H., Valle-Aguilera R., Lathrop D. A., Garcia M. C. Slow inward calcium currents have no obvious role in muscle excitation-contraction coupling. Nature. 1982 Jul 15;298(5871):292–294. doi: 10.1038/298292a0. [DOI] [PubMed] [Google Scholar]
  21. Hasselbach W., Oetliker H. Energetics and electrogenicity of the sarcoplasmic reticulum calcium pump. Annu Rev Physiol. 1983;45:325–339. doi: 10.1146/annurev.ph.45.030183.001545. [DOI] [PubMed] [Google Scholar]
  22. Herbette L., Messineo F. C., Katz A. M. The interaction of drugs with the sarcoplasmic reticulum. Annu Rev Pharmacol Toxicol. 1982;22:413–434. doi: 10.1146/annurev.pa.22.040182.002213. [DOI] [PubMed] [Google Scholar]
  23. Horne W. A., Abdel-Ghany M., Racker E., Weiland G. A., Oswald R. E., Cerione R. A. Functional reconstitution of skeletal muscle Ca2+ channels: separation of regulatory and channel components. Proc Natl Acad Sci U S A. 1988 Jun;85(11):3718–3722. doi: 10.1073/pnas.85.11.3718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hui C. S., Milton R. L., Eisenberg R. S. Charge movement in skeletal muscle fibers paralyzed by the calcium-entry blocker D600. Proc Natl Acad Sci U S A. 1984 Apr;81(8):2582–2585. doi: 10.1073/pnas.81.8.2582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hume J. R. Comparative interactions of organic Ca++ channel antagonists with myocardial Ca++ and K+ channels. J Pharmacol Exp Ther. 1985 Jul;234(1):134–140. [PubMed] [Google Scholar]
  26. Imagawa T., Smith J. S., Coronado R., Campbell K. P. Purified ryanodine receptor from skeletal muscle sarcoplasmic reticulum is the Ca2+-permeable pore of the calcium release channel. J Biol Chem. 1987 Dec 5;262(34):16636–16643. [PubMed] [Google Scholar]
  27. Inui M., Saito A., Fleischer S. Purification of the ryanodine receptor and identity with feet structures of junctional terminal cisternae of sarcoplasmic reticulum from fast skeletal muscle. J Biol Chem. 1987 Feb 5;262(4):1740–1747. [PubMed] [Google Scholar]
  28. Jaimovich E., Donoso P., Liberona J. L., Hidalgo C. Ion pathways in transverse tubules. Quantification of receptors in membranes isolated from frog and rabbit skeletal muscle. Biochim Biophys Acta. 1986 Feb 13;855(1):89–98. doi: 10.1016/0005-2736(86)90192-6. [DOI] [PubMed] [Google Scholar]
  29. Jenden D. J., Fairhurst A. S. The pharmacology of ryanodine. Pharmacol Rev. 1969 Mar;21(1):1–25. [PubMed] [Google Scholar]
  30. Kanaya S., Katzung B. G. Effects of diltiazem on transmembrane potential and current of right ventricular papillary muscle of ferrets. J Pharmacol Exp Ther. 1984 Jan;228(1):245–251. [PubMed] [Google Scholar]
  31. Kass R. S. Nisoldipine: a new, more selective calcium current blocker in cardiac Purkinje fibers. J Pharmacol Exp Ther. 1982 Nov;223(2):446–456. [PubMed] [Google Scholar]
  32. Lai F. A., Erickson H. P., Rousseau E., Liu Q. Y., Meissner G. Purification and reconstitution of the calcium release channel from skeletal muscle. Nature. 1988 Jan 28;331(6154):315–319. doi: 10.1038/331315a0. [DOI] [PubMed] [Google Scholar]
  33. Lattanzio F. A., Jr, Schlatterer R. G., Nicar M., Campbell K. P., Sutko J. L. The effects of ryanodine on passive calcium fluxes across sarcoplasmic reticulum membranes. J Biol Chem. 1987 Feb 25;262(6):2711–2718. [PubMed] [Google Scholar]
  34. Ma J., Fill M., Knudson C. M., Campbell K. P., Coronado R. Ryanodine receptor of skeletal muscle is a gap junction-type channel. Science. 1988 Oct 7;242(4875):99–102. doi: 10.1126/science.2459777. [DOI] [PubMed] [Google Scholar]
  35. McCleskey E. W. Calcium channels and intracellular calcium release are pharmacologically different in frog skeletal muscle. J Physiol. 1985 Apr;361:231–249. doi: 10.1113/jphysiol.1985.sp015643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Michalak M., Dupraz P., Shoshan-Barmatz V. Ryanodine binding to sarcoplasmic reticulum membrane; comparison between cardiac and skeletal muscle. Biochim Biophys Acta. 1988 Apr 22;939(3):587–594. doi: 10.1016/0005-2736(88)90106-x. [DOI] [PubMed] [Google Scholar]
  37. Mitchell R. D., Palade P., Fleischer S. Purification of morphologically intact triad structures from skeletal muscle. J Cell Biol. 1983 Apr;96(4):1008–1016. doi: 10.1083/jcb.96.4.1008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Nakamaru Y., Schwartz A. The influence of hydrogen ion concentration on calcium binding and release by skeletal muscle sarcoplasmic reticulum. J Gen Physiol. 1972 Jan;59(1):22–32. doi: 10.1085/jgp.59.1.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Nayler W. G., Szeto J. Effect of verapamil on contractility, oxygen utilization, and calcium exchangeability in mammalian heart muscle. Cardiovasc Res. 1972 Mar;6(2):120–128. doi: 10.1093/cvr/6.2.120. [DOI] [PubMed] [Google Scholar]
  40. Oeken H. J., von Nettelbladt E., Zimmer M., Flockerzi V., Ruth P., Hofmann F. Cardiac sarcoplasmic reticulum contains a low-affinity site for phenylalkylamines. Eur J Biochem. 1986 May 2;156(3):661–667. doi: 10.1111/j.1432-1033.1986.tb09629.x. [DOI] [PubMed] [Google Scholar]
  41. Pessah I. N., Francini A. O., Scales D. J., Waterhouse A. L., Casida J. E. Calcium-ryanodine receptor complex. Solubilization and partial characterization from skeletal muscle junctional sarcoplasmic reticulum vesicles. J Biol Chem. 1986 Jul 5;261(19):8643–8648. [PubMed] [Google Scholar]
  42. Pessah I. N., Stambuk R. A., Casida J. E. Ca2+-activated ryanodine binding: mechanisms of sensitivity and intensity modulation by Mg2+, caffeine, and adenine nucleotides. Mol Pharmacol. 1987 Mar;31(3):232–238. [PubMed] [Google Scholar]
  43. Pessah I. N., Waterhouse A. L., Casida J. E. The calcium-ryanodine receptor complex of skeletal and cardiac muscle. Biochem Biophys Res Commun. 1985 Apr 16;128(1):449–456. doi: 10.1016/0006-291x(85)91699-7. [DOI] [PubMed] [Google Scholar]
  44. Rousseau E., Ladine J., Liu Q. Y., Meissner G. Activation of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum by caffeine and related compounds. Arch Biochem Biophys. 1988 Nov 15;267(1):75–86. doi: 10.1016/0003-9861(88)90010-0. [DOI] [PubMed] [Google Scholar]
  45. Sanguinetti M. C., Kass R. S. Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists. Circ Res. 1984 Sep;55(3):336–348. doi: 10.1161/01.res.55.3.336. [DOI] [PubMed] [Google Scholar]
  46. Schwartz L. M., McCleskey E. W., Almers W. Dihydropyridine receptors in muscle are voltage-dependent but most are not functional calcium channels. 1985 Apr 25-May 1Nature. 314(6013):747–751. doi: 10.1038/314747a0. [DOI] [PubMed] [Google Scholar]
  47. Shoshan V., MacLennan D. H., Wood D. S. A proton gradient controls a calcium-release channel in sarcoplasmic reticulum. Proc Natl Acad Sci U S A. 1981 Aug;78(8):4828–4832. doi: 10.1073/pnas.78.8.4828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Sieber M., Nastainczyk W., Zubor V., Wernet W., Hofmann F. The 165-kDa peptide of the purified skeletal muscle dihydropyridine receptor contains the known regulatory sites of the calcium channel. Eur J Biochem. 1987 Aug 17;167(1):117–122. doi: 10.1111/j.1432-1033.1987.tb13311.x. [DOI] [PubMed] [Google Scholar]
  49. Sihra T. S., Scott I. G., Nicholls D. G. Ionophore A23187, verapamil, protonophores, and veratridine influence the release of gamma-aminobutyric acid from synaptosomes by modulation of the plasma membrane potential rather than the cytosolic calcium. J Neurochem. 1984 Dec;43(6):1624–1630. doi: 10.1111/j.1471-4159.1984.tb06087.x. [DOI] [PubMed] [Google Scholar]
  50. Smith J. S., Coronado R., Meissner G. Sarcoplasmic reticulum contains adenine nucleotide-activated calcium channels. Nature. 1985 Aug 1;316(6027):446–449. doi: 10.1038/316446a0. [DOI] [PubMed] [Google Scholar]
  51. Smith J. S., Coronado R., Meissner G. Single channel measurements of the calcium release channel from skeletal muscle sarcoplasmic reticulum. Activation by Ca2+ and ATP and modulation by Mg2+. J Gen Physiol. 1986 Nov;88(5):573–588. doi: 10.1085/jgp.88.5.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Smith J. S., Imagawa T., Ma J., Fill M., Campbell K. P., Coronado R. Purified ryanodine receptor from rabbit skeletal muscle is the calcium-release channel of sarcoplasmic reticulum. J Gen Physiol. 1988 Jul;92(1):1–26. doi: 10.1085/jgp.92.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Striessnig J., Zernig G., Glossmann H. Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter. Eur J Biochem. 1985 Jul 1;150(1):67–77. doi: 10.1111/j.1432-1033.1985.tb08989.x. [DOI] [PubMed] [Google Scholar]
  54. Sumbilla C., Inesi G. Rapid filtration measurements of Ca2+ release from cisternal sarcoplasmic reticulum vesicles. FEBS Lett. 1987 Jan 1;210(1):31–36. doi: 10.1016/0014-5793(87)81292-9. [DOI] [PubMed] [Google Scholar]
  55. Tanabe T., Beam K. G., Powell J. A., Numa S. Restoration of excitation-contraction coupling and slow calcium current in dysgenic muscle by dihydropyridine receptor complementary DNA. Nature. 1988 Nov 10;336(6195):134–139. doi: 10.1038/336134a0. [DOI] [PubMed] [Google Scholar]
  56. Tanabe T., Takeshima H., Mikami A., Flockerzi V., Takahashi H., Kangawa K., Kojima M., Matsuo H., Hirose T., Numa S. Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature. 1987 Jul 23;328(6128):313–318. doi: 10.1038/328313a0. [DOI] [PubMed] [Google Scholar]
  57. Valdivia H. H., Coronado R. Internal and external effects of dihydropyridines in the calcium channel of skeletal muscle. J Gen Physiol. 1990 Jan;95(1):1–27. doi: 10.1085/jgp.95.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Watanabe A. M., Besch H. R., Jr Subcellular myocardial effects of verapamil and D600: comparison with propranolol. J Pharmacol Exp Ther. 1974 Nov;191(2):241–251. [PubMed] [Google Scholar]
  59. Williams L. T., Jones L. R. Specific binding of the calcium antagonist [3H]nitrendipine to subcellular fractions isolated from canine myocardium. Evidence for high affinity binding to ryanodine-sensitive sarcoplasmic reticulum vesicles. J Biol Chem. 1983 May 10;258(9):5344–5347. [PubMed] [Google Scholar]

Articles from Biophysical Journal are provided here courtesy of The Biophysical Society

RESOURCES